Quality processes that support compliant development, reduce gaps, and ensure audit readiness from the start.
Quality systems determine how well a product holds up under regulatory review. Gaps in processes, documentation, or oversight often surface only during audits—when timelines and approvals are already at risk.
The focus here is on identifying those gaps early and strengthening systems before they are tested. This includes evaluating processes across development, clinical, and manufacturing functions, and aligning them with current GxP expectations.
Independent GxP audits across clinical, laboratory, and manufacturing environments to assess compliance and identify risks early and plan corrective action to face regulatory inspections.
Evaluation of vendors and partners to ensure compliance with regulatory and quality standards. Covers due diligence, qualification, and ongoing monitoring—reducing risk across supply chains and ensuring consistent, compliant operations.
General Inquiries
info@pharmaleaf.comPhone
+91 (80) 2228 5733